Everest Medicines Limited (FRA:6HN)
Germany · Delayed Price · Currency is EUR 4.300
+0.080 (1.90%)
At close: Jan 7, 2026
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of €1.53 billion as of January 9, 2026. Its market cap has decreased by -20.94% in one year.
Market Cap
1.53B
Enterprise Value
1.42B
Revenue
101.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.30
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 2.25B to 1.53B, a decrease of -32.30%. That is a compound annual growth rate of -7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.53B | 6.73% |
| Dec 31, 2025 | 1.43B | -26.27% |
| Dec 31, 2024 | 1.94B | 150.05% |
| Dec 29, 2023 | 775.42M | 20.25% |
| Dec 30, 2022 | 644.85M | -44.62% |
| Dec 31, 2021 | 1.16B | -44.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |